Results

Total Results: 1,134 records

Showing results for "days".

201. psychiatric-readmissions-protocols-140904 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/psychiatric-readmissions_research-protocol.pdf
     December 31, 2014 - and residential status.5 A decrease in number of psychiatric admissions, typically measured over 30 days … , 90 days, or 1 year, is an important measure of successful outpatient mental health treatment. … With increasing pressure to decrease health care costs, reducing hospital bed days (psychiatric or otherwise … We will provide materials for review 1 week before calls, with reminder emails to KIs 2 to 3 days before

202. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - Residents of long term care facilities (LTC) are at high risk, with up to 26.2 cases per 10,000 resident days … in LTC versus 6.5 cases per 10,000 patient days in hospitals.5,6 Incidence rates may increase by four … Days to resolution of symptoms (faster resolution may mean shorter window for transmission) 4. … Infection Intermediate outcomes  Appropriate antibiotic usage  Positive environmental cultures  Days

203. Hip-Fracture-Pain Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
     May 01, 2011 - benefits and adverse events associated with pain management approaches in the long term (beyond 30 days

204. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
     August 01, 2016 - alternative etiology, as an increase in serum creatinine of more than 25 percent or 0.5 mg/dL within 2 to 3 days

205. Disposition of Comments Report for Recurrent Nephrolithiasis in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
     July 26, 2012 - Disposition of Comments Report for Recurrent Nephrolithiasis in Adults http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=1035 Published Online: July 26, 2012 Comparative Effectiveness Research Review Disposition of Comments Report Research Revie…

206. Comparing Talk Therapy and Other Depression Treatments With Antidepressant Medicines (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/major-depressive-disorder_consumer.pdf
     September 01, 2016 - that happen only during the winter when there is less sunlight) »Dysthymia (mild depression on most days … Depression is different from feeling sad or down for a few days.

207. Having a breast biopsy. A review of the research for women and thier families (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_consumer.pdf
     May 01, 2016 - You may need to stop taking some medicines a few days before the biopsy. … Preparing for a biopsy � How many days before my biopsy should I stop taking aspirin?

208. Cer-250-Cannabis-2024-Surv-Rep-Update-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
     January 01, 2024 - Baseline: 1,514 4-year followup: 1,217 Groups unclear A: Self-reported frequent cannabis use (≥20 days

209. Comparative Effectiveness of Pain Management Interventions fo Hip Fracture (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hip-fracture-pain.ppt
     May 01, 2011 - adults, what is the effectiveness of pain management interventions for controlling acute (up to 30 days … For hip fracture studies, the duration for acute pain is defined as occurring up to 30 days postfracture … Timing: acute care, within 30 days of fracture. Setting: acute care. … Timing: acute care, within 30 days of fracture. Setting: acute care. … benefits and adverse events associated with pain management approaches in the long term (beyond 30 days

210. Comparative Effectiveness of Pain Management Interventions fo Hip Fracture (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain.ppt
     May 01, 2011 - adults, what is the effectiveness of pain management interventions for controlling acute (up to 30 days … For hip fracture studies, the duration for acute pain is defined as occurring up to 30 days postfracture … Timing: acute care, within 30 days of fracture. Setting: acute care. … Timing: acute care, within 30 days of fracture. Setting: acute care. … benefits and adverse events associated with pain management approaches in the long term (beyond 30 days

211. Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
     March 01, 2012 - in last 12 weeks or greater) or community-onset (symptom onset in the community or within first 3 days … leads to increased relapse rates and that 10-14 days should be given. … amount of data, we do not feel that further speculation on the consequences of treatment for < 10 days … warranted, but have highlighted the fact that the most frequently studied therapy duration was 10 days … As discussed above, only 2 of 10 studies used treatment duration < 10 days, and one did not report

212. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - Patients treated with collaborative care reported more depression-free days during a12-month period … Patients treated with collaborative care reported more depression-free days during the 12 months than … Patients treated with fecal bacteriotherapy had a mean time to resolution of diarrhea of 6 days. … Stool for CDT was negative in 10 of 10 patients tested 30 or more days after transplantation. … If it does not, the patient may be treated with either oral metronidazole or vancomycin for 10 days

213. Disposition of Comments_Systematic Review: The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-disposition-comments_0.pdf
     March 03, 2025 - Disposition of Comments_Systematic Review: The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition Systematic Review Disposition of Comments Report Title: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabete…

214. Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-executive-summary-2023-update.pdf
     January 01, 2023 - Executive Summary - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update Comparative Effectiveness Review Number 250 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update Executive Summary Main Points …

215. Kidney-Stones-Draft-Appendi-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
     January 01, 2024 - /day, 1–2 meatless days/week, low-purine diet Mild hyperoxaluria: Firm restriction of oxalate-rich diet … Placebo: 2 capsules, orally, with each meal/snack, 3 to 5 times per day for 28 days NA NA NA 4 weeks … for HCTZ and 176 days for CLT NR 89 or 112 (unclear but seems more likely was 89) 112 51.4 years 49 … PMID: 38432593. 2 years (starting 1 year after 24-hour urine collection) N (%) with >80% days covered … PMID: 23660825. 186 days (HCTZ) and 176 days (CLT) NR, although authors say that patients clearly documented

216. S77 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s77.pdf
     October 01, 2007 - ORIGINAL ARTICLE Out-of-Pocket Pharmacy Expenditures for Veterans Under Medicare Part D Randall W. Rupper, MD, MPH,*†‡ Byron D. Bair, MD,*‡ Brian C. Sauer, PhD,†‡ Jonathan R. Nebeker, MD, MS,*†‡ Judith Shinogle, PhD,§¶ and Matthew Samore, MD†‡ Objectives: Because the VA pharmacy benefit is deemed equivalent coverage…

217. Eising_Panel_2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/eising_panel_2.pdf
     January 01, 2010 - Eising_Panel_2 Slide  1: White  Paper 2 Opening  Comments Scott W. Eising Director, Advanced Market/Product Development Mayo Clinic Rochester, MN Slide  2: Make Content Accessible • Create once, but design system to  be compatible with  a variety of platforms (print, W…

218. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
     January 01, 2012 - require hospitalization and corticosteroid infusion. 10 If the patient does not improve after 3–5 days … of treatment, 54% of patients treated with teduglutide were able to reduce the number of infusion days … per week by 1 or more days, compared with 23% of patients treated with placebo (p=0.005). 44 … Additionally, after 12 months of treatment with teduglutide, 53% of patients reduced their infusion days … per week, and 24% of patients reduced their infusion days per week by 3 or more days.

219. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
     April 18, 2012 - safety/medwatch/howtoreport/ucm053087.htm Timing: • KQs 1–4: Outcomes must be measured at ≥ 90 days … < 90 days Setting • Outpatient mental health and outpatient general medical settings • Community … Key Questions KQs 1–4: Outcomes must be measured at ≥ 90 days KQs 1–4: Outcomes must be … Methods (Timing) Exclusion Criteria: < 90 days Exclusion Criteria: < 2 months We have shortened … Comparators None None Outcomes < 90 days ≥ 90 days Timing Hospital inpatient setting Setting

220. PKU Surveillance Assessment_CER 56_Low (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
     January 15, 2013 - PKU Surveillance Assessment_CER 56_Low CER #56: Adjuvant Treatment for Phenylketonuria (PKU) Original release date: February 2012 Surveillance Report: January 2013 Key Findings: • All conclusions for KQ1-7 are still considered valid • No new significant safety concerns were identified. • Sever…